6794 XiangRong BioTech: Announcement of Key Resolutions at 2026 Annual General Meeting
XiangRong BioTech held its AGM on May 20, 2026, approving financial reports, the election of directors, and proposals for private placement and stock-based incentives.
📋 Article Processing Timeline
- 📰 Published: May 21, 2026 at 06:31
- 🔍 Collected: May 21, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 21, 2026 at 07:08 (36 min after Collected)
Announcement Date: May 20, 2026
Company Code: 6794
Company Name: XiangRong BioTech
Subject: Announcement of key resolutions from the 2026 Annual General Meeting.
1. Meeting Date: 05/20/2026
2. Resolution 1 (Earnings distribution/loss offsetting): Approved the loss offsetting proposal for fiscal year 2025.
3. Resolution 2 (Amendment to Articles of Incorporation): Approved the amendment proposal.
4. Resolution 3 (Business report and financial statements): Approved the business report and financial statements for fiscal year 2025.
5. Resolution 4 (Election of Directors): Elected 9 directors for the 6th term (including 3 independent directors).
6. Resolution 5 (Other matters):
(1) Approved the lifting of non-compete restrictions for newly appointed directors.
(2) Approved the amendment of the 'Procedures for Acquisition or Disposal of Assets'.
(3) Approved the proposal for the first private placement of common stock for 2026.
(4) Approved the proposal for the issuance of new restricted stock awards for employees for 2026.
Company Code: 6794
Company Name: XiangRong BioTech
Subject: Announcement of key resolutions from the 2026 Annual General Meeting.
1. Meeting Date: 05/20/2026
2. Resolution 1 (Earnings distribution/loss offsetting): Approved the loss offsetting proposal for fiscal year 2025.
3. Resolution 2 (Amendment to Articles of Incorporation): Approved the amendment proposal.
4. Resolution 3 (Business report and financial statements): Approved the business report and financial statements for fiscal year 2025.
5. Resolution 4 (Election of Directors): Elected 9 directors for the 6th term (including 3 independent directors).
6. Resolution 5 (Other matters):
(1) Approved the lifting of non-compete restrictions for newly appointed directors.
(2) Approved the amendment of the 'Procedures for Acquisition or Disposal of Assets'.
(3) Approved the proposal for the first private placement of common stock for 2026.
(4) Approved the proposal for the issuance of new restricted stock awards for employees for 2026.
FAQ
When was XiangRong BioTech's shareholder meeting held?
It was held on May 20, 2026 (115/05/20).
What were the main resolutions?
Approvals included financial reports, loss offsetting, private placement, and restricted stock awards.
Was there a change in board composition?
Yes, nine directors were elected, including three independent directors.